OraSure Technologies to Present at the Raymond James 34th Annual Institutional Investors Conference

OraSure Technologies to Present at the Raymond James 34th Annual Institutional
Investors Conference

BETHLEHEM, Pa., Feb. 22, 2013 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc.
(Nasdaq:OSUR) today announced that Douglas A. Michels, President and CEO, will
speak to the investment community at the Raymond James 34^th Annual
Institutional Investors Conference in Orlando, Florida. The conference will be
simultaneously webcast over the Internet.

Mr. Michels is scheduled to speak March 4, 2013, at approximately 10:25 am
Eastern Time (7:25 am Pacific Time). Interested investors can access the live
webcast of the presentation by going to OraSure Technologies' web site,
www.orasure.com, and clicking on the Investor Info link. A replay of the
webcast will be available on OraSure Technologies' web site for seven days.
Alternatively, you can access the live webcast of the presentation via the
following link http://wsw.com/webcast/rj82/osur/.

About OraSure Technologies

OraSure Technologies is a leader in the development, manufacture and
distribution of oral fluid diagnostic and collection devices and other
technologies designed to detect or diagnose critical medical conditions. Its
innovative products include rapid tests for the detection of antibodies to HIV
and HCV at the point of care and testing solutions for detecting various drugs
of abuse. In July 2012, the Company received approval from the U.S. Food and
Drug Administration for the Company's OraQuick^® In-Home HIV Test for sale
directly to consumers in the over-the-counter (OTC) market – making it the
first and only rapid OTC HIV test approved in the U.S. In addition, the
Company is a leading provider of oral fluid sample collection, stabilization
and preparation products for molecular diagnostic applications. OraSure's
portfolio of products is sold globally to various clinical laboratories,
hospitals, clinics, community-based organizations and other public health
organizations, research and academic institutions, distributors, government
agencies, physicians' offices, and commercial and industrial entities. The
Company's products enable healthcare providers to deliver critical information
to patients, empowering them to make decisions to improve and protect their
health.

The OraSure Technologies, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=6440

For more information on OraSure Technologies, please visit www.orasure.com.

CONTACT: Ronald H. Spair
         Chief Financial Officer
         610-882-1820
         Investorinfo@orasure.com
         www.orasure.com

company logo
 
Press spacebar to pause and continue. Press esc to stop.